Remogliflozin Etabonate + Vildagliptin is primarily used to enhance glycemic control in individuals suffering from type 2 diabetes mellitus and is part of the class of antidiabetic medications.
Upper respiratory tract infections
Nasopharyngitis
Headache
Urinary tract infections
Genital fungal infections
Remogliflozin Etabonate is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. In simple terms, it blocks the absorption of glucose in the kidneys and promotes its removal through urine. This process reduces the amount of glucose that goes back into your blood, thereby lowering the levels of blood sugar.
Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by blocking an enzyme (DPP-4) that usually breaks down hormones responsible for insulin production. By inhibiting DPP-4, vildagliptin extends the lifespan of these hormones, hence prolonging their insulin-producing effect. This leads to more insulin release when your body needs it and less glucose production by your liver.
Together, remogliflozin etabonate and vildagliptin help control blood sugar levels in type 2 diabetes patients by reducing glucose production and absorption while stimulating insulin production when needed.
Bachelor of Dental Surgery
Doctor of Medicine
Remogliflozin Etabonate + Vildagliptin can be taken orally (tablets).
This medicine is meant for adults only of age above 18 years.
This medicine is contraindicated in patients with hypersensitivity to any component of the medication.
It is not recommended for treatment of type 1 diabetes or diabetic ketoacidosis.
Remogliflozin Etabonate + Vildagliptin may interact with digoxin (like lanoxin) and medicines metabolized by CYP3A4 (such as simvastatin).
An overdose of this medication may lead to hypoglycemia. If you observe this symptom, inform your doctor and follow the advice accordingly.
If you forget to take this medicine, take it as soon as you remember. However, if it's nearly time for your next dose, skip the missed dose and continue with your regular schedule. Do not double doses.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any symptoms, please consult your doctor.
For common side effects like nasopharyngitis, ensure to rest and stay hydrated.
For headaches, try a cool compress on your forehead or at the back of your neck.
This medication does not generally affect your ability to drive or operate heavy machinery. However, if you experience dizziness or drowsiness after taking this medication, avoid driving or operating machines.
Always consult your doctor before using this medicine if you're pregnant or breastfeeding.
Patients with severe renal impairment should avoid using this medication.
Caution should also be taken by patients at risk for volume depletion, hypotension and electrolyte imbalances.
Maintain a healthy diet. Focus on foods lower in fat and calories, especially if you're overweight.
Include physical activity in your daily routine. Aim for 30 minutes of moderate physical activity most days of the week.
Regularly monitor blood sugar levels to ensure the medication is working effectively.
Regular check-ups with your doctor to keep track of your progress and adjust the medication if necessary.
Frequently asked questions
Since the active ingredients in Remogliflozin Etabonate + Vildagliptin are purely chemical substances, they should be suitable for vegan consumption. However, you should consult a doctor or pharmacist about the inactive ingredients and excipients present in the tablet, as some of these might be sourced from non-vegan origins.
The half-life of remogliflozin etabonate is approximately 2-3 hours and that of vildagliptin is 2-4 hours. This suggests that most of the medicine would be cleared from your system within a day. However, this can vary depending on individual factors such as your metabolism, age, health status, and other medicines you are taking.
Remogliflozin Etabonate + Vildagliptin is not directly associated with affecting mood. However, maintaining a stable blood sugar level can contribute to overall mood stability. If you experience any significant changes in your mood after starting this medication, please consult your doctor.
Remogliflozin Etabonate + Vildagliptin is not typically associated with weight gain. In fact, some patients may experience weight loss due to the enhanced glucose excretion in urine caused by remogliflozin etabonate.
While there's no direct natural alternative to this medicine, a balanced diet and regular exercise play a critical role in managing type 2 diabetes. Foods rich in fibre and low in saturated fat can help control blood glucose levels. However, these should not replace your prescribed medication but rather complement it.
Remogliflozin Etabonate + Vildagliptin is not associated with affecting menstrual cycle. If you notice any irregularities, consult your doctor.
Remogliflozin Etabonate + Vildagliptin does not cause dependency or withdrawal symptoms. It is a prescription medication used for managing type 2 diabetes.
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.14
Our Payment Partners